FORBES-TATE

Lobbying for IONIS PHARMACEUTICAL, INC. · Biopharmaceutical company developing RNA therapies.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income · posted Oct 19, 2025

Bills named in this filing 1

Lobbying activity 2

Health Issues

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Medicare/Medicaid

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.